Is Vivos Therapeutics, Inc. (VVOS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 10.0% / 30% | 41.2% / 30% | 2.8% / 30% | 0.23% / 5% | ✗ NOT HALAL |
| DJIM | 10.0% / 33% | 41.2% / 33% | 2.8% / 33% | 0.23% / 5% | ✗ NOT HALAL |
| MSCI | 9.9% / 33% | 41.0% / 33% | 2.8% / 33% | 0.23% / 5% | ✗ NOT HALAL |
| S&P | 10.0% / 33% | 41.2% / 33% | 2.8% / 33% | 0.23% / 5% | ✗ NOT HALAL |
| FTSE | 9.9% / 33% | 41.0% / 33% | 2.8% / 50% | 0.23% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 55.7% | |
| Operating Margin | -69.8% | |
| Net Margin | -98.8% | |
| Return on Equity (ROE) | -335.5% | |
| Return on Assets (ROA) | -49.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$13M |
| Free Cash Flow | -$13M |
| Total Debt | $2M |
| Debt-to-Equity | 493.6 |
| Current Ratio | 0.8 |
| Total Assets | $15M |
Price & Trading
| Last Close | $1.19 |
| 50-Day MA | $1.51 |
| 200-Day MA | $2.89 |
| Avg Volume | 125K |
| Beta | 7.0 |
|
52-Week Range
$1.09
| |
About Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Vivos Therapeutics, Inc. (VVOS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Vivos Therapeutics, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Vivos Therapeutics, Inc.'s debt ratio?
Vivos Therapeutics, Inc.'s debt ratio is 10.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 9.9%.
What are Vivos Therapeutics, Inc.'s key financial metrics?
Vivos Therapeutics, Inc. has a market capitalization of $13M, and revenue of $15M. The company maintains a gross margin of 55.7% and a net margin of -98.8%. Return on equity stands at -335.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.